Oncoredox
Oncoredox provides rapid, noninvasive cancer detection and monitoring by analyzing urine and blood metabolites to produce a metabolic fingerprint. The company combines a proprietary disposable electrochemical sensor with AI-driven analysis based on its 'Redox-omics' approach to detect and profile cell-free metabolites within minutes. The product is a medical diagnostics platform (hardware + AI) intended for clinical and laboratory settings to support early diagnosis and disease monitoring. Oncoredox targets hospitals, diagnostic labs, and oncology clinics seeking faster metabolic-based cancer screening and longitudinal monitoring. The technology addresses cancer and chronic disease diagnostics with a focus on speed, point-of-care utility, and metabolic biomarker profiling.
Oncoredox
Oncoredox provides rapid, noninvasive cancer detection and monitoring by analyzing urine and blood metabolites to produce a metabolic fingerprint. The company combines a proprietary disposable electrochemical sensor with AI-driven analysis based on its 'Redox-omics' approach to detect and profile cell-free metabolites within minutes. The product is a medical diagnostics platform (hardware + AI) intended for clinical and laboratory settings to support early diagnosis and disease monitoring. Oncoredox targets hospitals, diagnostic labs, and oncology clinics seeking faster metabolic-based cancer screening and longitudinal monitoring. The technology addresses cancer and chronic disease diagnostics with a focus on speed, point-of-care utility, and metabolic biomarker profiling.